Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

February 28, 2025

Conditions
Gut MicrobiotaMetabolic ProfilesHelicobacter Pylori InfectionSmall Intestinal Bacterial Overgrowth
Interventions
DIAGNOSTIC_TEST

13C-Urea Breath Test

Participants underwent the 13C-urea breath test following a standardized protocol to detect active Helicobacter pylori (H. pylori) infection. After an overnight fast (≥8 hours), baseline breath samples were collected by exhaling gently through a straw. Participants then ingested 75 mg of 13C-labeled urea dissolved in 50 mL of citric acid solution to delay gastric emptying and maximize urease exposure. A second breath sample was collected 30 minutes post-ingestion using identical procedures.

DIAGNOSTIC_TEST

Hydrogen-Methane Breath Test

Participants underwent a standardized hydrogen-methane breath test to evaluate for small intestinal bacterial overgrowth (SIBO) or carbohydrate malabsorption. After a 12-hour overnight fast, baseline breath samples were collected via controlled end-expiratory exhalation. Participants then ingested a substrate solution.

Trial Locations (1)

361015

Zhongshan Hospital (Xiamen), Fudan University, Xiamen

All Listed Sponsors
lead

Zhongshan Hospital (Xiamen), Fudan University

OTHER

NCT07122284 - Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity | Biotech Hunter | Biotech Hunter